BR9607057A - Composições farmacêuticas compreendendo inibidores monoamina oxidase b - Google Patents
Composições farmacêuticas compreendendo inibidores monoamina oxidase bInfo
- Publication number
- BR9607057A BR9607057A BR9607057A BR9607057A BR9607057A BR 9607057 A BR9607057 A BR 9607057A BR 9607057 A BR9607057 A BR 9607057A BR 9607057 A BR9607057 A BR 9607057A BR 9607057 A BR9607057 A BR 9607057A
- Authority
- BR
- Brazil
- Prior art keywords
- monoamine oxidase
- inhibitors
- pharmaceutical compositions
- active ingredient
- buccal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9504235.4A GB9504235D0 (en) | 1995-03-02 | 1995-03-02 | Pharmaceutical compositon |
GBGB9517063.5A GB9517063D0 (en) | 1995-03-02 | 1995-08-18 | Pharmaceutical composition |
PCT/GB1996/000484 WO1996026720A1 (en) | 1995-03-02 | 1996-03-01 | Pharmaceutical compositions comprising monoamine oxidase b inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9607057A true BR9607057A (pt) | 1998-06-09 |
Family
ID=26306612
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9607057A BR9607057A (pt) | 1995-03-02 | 1996-03-01 | Composições farmacêuticas compreendendo inibidores monoamina oxidase b |
Country Status (26)
Country | Link |
---|---|
US (3) | US20010021722A1 (pt) |
EP (1) | EP0814789B2 (pt) |
JP (1) | JP3273141B2 (pt) |
CN (1) | CN1171586C (pt) |
AT (1) | ATE241346T1 (pt) |
AU (1) | AU702161B2 (pt) |
BG (1) | BG63862B1 (pt) |
BR (1) | BR9607057A (pt) |
CA (1) | CA2214026C (pt) |
CZ (1) | CZ297382B6 (pt) |
DE (1) | DE69628415T3 (pt) |
DK (1) | DK0814789T4 (pt) |
EE (1) | EE04039B1 (pt) |
ES (1) | ES2199283T5 (pt) |
GE (1) | GEP20012374B (pt) |
HU (1) | HU228852B1 (pt) |
IS (1) | IS2789B (pt) |
MX (1) | MX9706647A (pt) |
NO (1) | NO316804B1 (pt) |
NZ (2) | NZ329471A (pt) |
PL (1) | PL183266B1 (pt) |
PT (1) | PT814789E (pt) |
SI (1) | SI0814789T2 (pt) |
SK (1) | SK284383B6 (pt) |
TR (1) | TR199700878T1 (pt) |
WO (1) | WO1996026720A1 (pt) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5744500A (en) | 1990-01-03 | 1998-04-28 | Teva Pharmaceutical Industries, Ltd. | Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof |
US5844003A (en) * | 1991-04-04 | 1998-12-01 | Innovations Foundation | Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function |
CA2212412A1 (en) | 1995-02-10 | 1996-08-15 | The University Of Toronto Innovations Foundation | Deprenyl compounds for treatment of glaucoma |
IL115357A (en) * | 1995-09-20 | 2000-01-31 | Teva Pharma | Stable compositions containing N-propargyl-1-aminoindan and polyhydric alcohols |
DK0866691T4 (da) * | 1995-11-06 | 2005-06-06 | Somerset Pharmaceuticals Inc | Medikamenter til sublingual og bukkal administration af selegilin |
GB9715082D0 (en) * | 1997-07-17 | 1997-09-24 | Scherer Ltd R P | Treatment of attention deficit hyperactivity disorder and narcolepsy |
GB9717770D0 (en) * | 1997-08-21 | 1997-10-29 | Scherer Ltd R P | Pharmaceutical composition |
GB9802088D0 (en) * | 1998-01-30 | 1998-03-25 | Scherer Ltd R P | Pharmaceutical products |
DE69918339T2 (de) * | 1999-04-21 | 2005-08-25 | Yuyu Inc., Anyang | Pharmazeutische zusammensetzungen die selegilin und ginkgo biloba extrakt enthalten zur behandlung von demenz |
US20050089502A1 (en) * | 2003-08-21 | 2005-04-28 | Todd Schansberg | Effervescent delivery system |
ZA200704917B (en) * | 2004-11-24 | 2008-11-26 | Teva Pharma | Rasagiline orally disintegrating compositions |
NZ555470A (en) * | 2004-11-24 | 2011-02-25 | Teva Pharma | Rasagiline orally disintegrating compositions |
AU2006265639A1 (en) | 2005-07-01 | 2007-01-11 | Jenrin Discovery | MAO-B inhibitors useful for treating obesity |
CN1911211B (zh) * | 2006-08-25 | 2010-04-14 | 重庆医药工业研究院有限责任公司 | 雷沙吉兰口服固体制剂 |
EP1897543A1 (en) | 2006-08-30 | 2008-03-12 | Euro-Celtique S.A. | Buprenorphine- wafer for drug substitution therapy |
US20070190187A1 (en) * | 2006-09-07 | 2007-08-16 | Kneller Bruce W | Formulation for enhanced delivery of phenethylamine |
EP2053033A1 (en) | 2007-10-26 | 2009-04-29 | Bayer Schering Pharma AG | Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors |
WO2010144943A1 (en) * | 2009-05-20 | 2010-12-23 | Ozpharma Pty Ltd | Buccal and/or sublingual therapeutic formulation |
US8475832B2 (en) | 2009-08-07 | 2013-07-02 | Rb Pharmaceuticals Limited | Sublingual and buccal film compositions |
CN102048717B (zh) * | 2009-10-29 | 2014-02-19 | 重庆医药工业研究院有限责任公司 | 一种稳定的雷沙吉兰组合物 |
EP2450332A1 (en) * | 2010-10-22 | 2012-05-09 | Bayer Pharma Aktiengesellschaft | Compounds for use in Imaging, diagnosing and/or treatment of diseases of the central nervous system (F-D2-Deprenyl) |
WO2013175493A1 (en) | 2012-04-09 | 2013-11-28 | Cadila Healthcare Limited | Stable oral pharmaceutical compositions |
CN109152841A (zh) | 2016-03-26 | 2019-01-04 | 雷迪博士实验室有限公司 | N-炔丙胺衍生物的药物组合物 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1227447B (de) * | 1962-03-30 | 1966-10-27 | Chinoin Gyogyszer Es Vegyeszet | Verfahren zur Herstellung von Phenylisopropylaminen |
GB1548022A (en) * | 1976-10-06 | 1979-07-04 | Wyeth John & Brother Ltd | Pharmaceutial dosage forms |
CA1097233A (en) * | 1977-07-20 | 1981-03-10 | George K. E. Gregory | Packages |
US4454158A (en) * | 1981-06-01 | 1984-06-12 | Merrell Toraude Et Compagnie | Allyl amine MAO inhibitors |
IE53696B1 (en) * | 1981-12-02 | 1989-01-18 | Wyeth John & Brother Ltd | Solid shaped articles |
DE3779500T2 (de) * | 1986-06-10 | 1993-01-21 | Chiesi Farma Spa | Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen. |
HU197510B (en) * | 1986-12-19 | 1989-04-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing pharmaceutical composition containing phenyl-alkyl-amine derivatives, against motion-sick |
JP2660419B2 (ja) * | 1988-04-02 | 1997-10-08 | 旭電化工業株式会社 | 安定化された合成樹脂組成物 |
US4866046A (en) * | 1988-05-31 | 1989-09-12 | Top Laboratories, Inc. | Low-dosage sublingual aspirin |
HU208484B (en) * | 1988-08-17 | 1993-11-29 | Chinoin Gyogyszer Es Vegyeszet | Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia |
US5055303A (en) * | 1989-01-31 | 1991-10-08 | Kv Pharmaceutical Company | Solid controlled release bioadherent emulsions |
US5079018A (en) * | 1989-08-14 | 1992-01-07 | Neophore Technologies, Inc. | Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs |
IL92952A (en) * | 1990-01-03 | 1994-06-24 | Teva Pharma | R-enantiomers of n-propargyl-1-aminoindan compounds, their preparation and pharmaceutical compositions containing them |
US5192550A (en) † | 1990-05-07 | 1993-03-09 | Alza Corporation | Dosage form for treating central nervous system disorders |
GB9017610D0 (en) * | 1990-08-10 | 1990-09-26 | Erba Carlo Spa | Antiparkinson mao reversible inhibitor |
ATE172637T1 (de) † | 1991-12-24 | 1998-11-15 | Yamanouchi Pharma Co Ltd | Intrabukkal desintegrierende zubereitung und ihre herstellung |
US5298261A (en) * | 1992-04-20 | 1994-03-29 | Oregon Freeze Dry, Inc. | Rapidly distintegrating tablet |
US5607691A (en) * | 1992-06-12 | 1997-03-04 | Affymax Technologies N.V. | Compositions and methods for enhanced drug delivery |
AU4534593A (en) † | 1992-06-12 | 1994-01-04 | Affymax Technologies N.V. | Compositions and methods for enhanced drug delivery |
IL111240A (en) * | 1993-10-18 | 2001-10-31 | Teva Pharma | Salts of r(+) - enantiomers of n- propargyl-1-aminoindan and pharmaceutical compositions comprising them |
DK0866691T4 (da) * | 1995-11-06 | 2005-06-06 | Somerset Pharmaceuticals Inc | Medikamenter til sublingual og bukkal administration af selegilin |
-
1996
- 1996-03-01 CZ CZ0270597A patent/CZ297382B6/cs not_active IP Right Cessation
- 1996-03-01 NZ NZ329471A patent/NZ329471A/en not_active IP Right Cessation
- 1996-03-01 WO PCT/GB1996/000484 patent/WO1996026720A1/en active IP Right Grant
- 1996-03-01 PL PL96322046A patent/PL183266B1/pl unknown
- 1996-03-01 US US08/894,764 patent/US20010021722A1/en not_active Abandoned
- 1996-03-01 HU HU9801227A patent/HU228852B1/hu unknown
- 1996-03-01 GE GEAP19963934A patent/GEP20012374B/en unknown
- 1996-03-01 PT PT96904929T patent/PT814789E/pt unknown
- 1996-03-01 AT AT96904929T patent/ATE241346T1/de active
- 1996-03-01 EE EE9700187A patent/EE04039B1/xx unknown
- 1996-03-01 DE DE69628415T patent/DE69628415T3/de not_active Expired - Lifetime
- 1996-03-01 EP EP96904929A patent/EP0814789B2/en not_active Expired - Lifetime
- 1996-03-01 SI SI9630617T patent/SI0814789T2/sl unknown
- 1996-03-01 BR BR9607057A patent/BR9607057A/pt not_active Application Discontinuation
- 1996-03-01 NZ NZ302723A patent/NZ302723A/en not_active IP Right Cessation
- 1996-03-01 JP JP52610896A patent/JP3273141B2/ja not_active Expired - Lifetime
- 1996-03-01 CN CNB961923032A patent/CN1171586C/zh not_active Expired - Lifetime
- 1996-03-01 DK DK96904929T patent/DK0814789T4/da active
- 1996-03-01 CA CA002214026A patent/CA2214026C/en not_active Expired - Lifetime
- 1996-03-01 SK SK1158-97A patent/SK284383B6/sk not_active IP Right Cessation
- 1996-03-01 TR TR97/00878T patent/TR199700878T1/xx unknown
- 1996-03-01 ES ES96904929T patent/ES2199283T5/es not_active Expired - Lifetime
- 1996-03-01 AU AU48846/96A patent/AU702161B2/en not_active Expired
-
1997
- 1997-08-27 IS IS4553A patent/IS2789B/is unknown
- 1997-09-01 NO NO19974010A patent/NO316804B1/no not_active IP Right Cessation
- 1997-09-02 MX MX9706647A patent/MX9706647A/es unknown
- 1997-10-01 BG BG101937A patent/BG63862B1/bg unknown
-
2003
- 2003-07-01 US US10/610,613 patent/US20040091525A1/en not_active Abandoned
-
2007
- 2007-09-05 US US11/850,141 patent/US20080187573A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9607057A (pt) | Composições farmacêuticas compreendendo inibidores monoamina oxidase b | |
ATE525061T1 (de) | Feste selbst-haftende zusammensetzungen zur topischen behandlung von störungen der mundschleimhaut | |
ATE153853T1 (de) | Stabile, orale und absorbierbare therapeutische zusammensetzungen von nadh und nadph | |
BR9808948A (pt) | Composição de confeitaria | |
PT706398E (pt) | Composicao farmaceutica contendo heparina fragmentos de heparina ou seus derivados em combinacao com esteres de glicerol | |
ATE286500T1 (de) | 1,2,3,4-tetrahydroisochinolin-derivate | |
DE69932864D1 (de) | Neue Fettsäureanaloge zur Behandlung des Bluthochdrucks | |
DE60323765D1 (de) | Inhibitoren der 17 beta-hydroxysteroiddehydrogenase des typs 3 zur behandlung androgenabhängiger krankheiten | |
NZ513096A (en) | Compositions for treating inflammatory response | |
DE69802113D1 (de) | Zusammensetzungen zur erhöhung der konzentration und/oder beweglichkeit von samenzellen in menschen | |
EA199900876A1 (ru) | Фармацевтические композиции против кашля | |
WO2001034172A3 (en) | Methods and compositions for treating reward deficiency syndrome | |
PT888327E (pt) | Derivados de benzopirano que possuem uma accao antagonistica dos leucotrienos | |
DE60225143D1 (de) | Synergistische pharmazeutische zusammensetzungen zur behandlung bzw. prophylaxe von diabetes | |
HK1068332A1 (en) | Pyrane derivatives as both ace-and nep-inhibitors | |
SE0004101D0 (sv) | New use | |
ATE159511T1 (de) | Derivate von n,n,n',n'-tetrasubstituierten 1,2- ethylendiamin-verbindungen | |
DK1546067T3 (da) | Rygesammensætning | |
TWI262791B (en) | 6-methoxy-2-naphthylacetic acid prodrugs | |
IT1274483B (it) | Composizioni farmaceutiche contenenti gemfibrozil | |
ATE342060T1 (de) | Pharmazeutische zusammensetzungen zur behandlung von herpes zoster | |
GT199400048A (es) | Composicion farmaceutica y proceso para su preparacion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B12B | Appeal against refusal [chapter 12.2 patent gazette] |